ArticleJournal of medicinal chemistry2022

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-

Stefano Sainas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.